🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether ublituximab in combinatio...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2012-11-21
Trial ID
NCT01744912
Treatments Being Tested
The purpose of this clinical trial is to learn how the experimental medicin...
Status
Terminated
Location
Keck Hospital of USC
Start Date
2018-05-14
Trial ID
NCT03530683
To explore the efficacy and safety of TQB2825 injection combined immunochem...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2025-04-23
Trial ID
NCT06829771
Treatments Being Tested
This non-randomized, open label, multi-site, first-in-human, Phase 1/2 stud...
Status
Terminated
Location
Stanford Cancer Institute
Start Date
2022-01-24
Trial ID
NCT05169489
Treatments Being Tested
To determine the safety, toxicity, and maximum tolerated dose (MTD) of CD19...
Status
Not Yet Recruiting
Location
Roswell Park Comprehensive Cancer Center
Start Date
2026-10
Trial ID
NCT07701889
Treatments Being Tested
This is a single centre prospective observational study to assess the immun...
Status
Completed
Location
Oncology Institute of Southern Switzerland
Start Date
2021-02-25
Trial ID
NCT04800146
Treatments Being Tested
A single-arm, open-label, multi-center clinical study of glofitamab combine...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2025-08-11
Trial ID
NCT07460362
Treatments Being Tested
This study intends to use Obinutuzumab, Zanubrutinib, and Lenalidomide sequ...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2022-07-01
Trial ID
NCT05797948
This is a single-center, phase 2, open-label clinical trial of a novel comb...
Status
Not Yet Recruiting
Location
Rhode Island Hospital
Start Date
2026-05-01
Trial ID
NCT07502872
Treatments Being Tested
This is an open-label, multicenter, Phase I/II study designed to evaluate t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-01
Trial ID
NCT07432022
Treatments Being Tested